CareDx, Inc. (CDNA) income statement
CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 12/3027% above fair value
$71.92−2.52 (-3.39%)
Close on Nov 19, 2026Market cap $3.78BP/E 30.1Yield –
CareDx, Inc. financial ratios
See a number that looks wrong?